Photo of Laurids Østergaard Poulsen

Laurids Østergaard Poulsen

  • Denmark

20132020
If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 33 Similar Profiles
Rectal Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Denmark Medicine & Life Sciences
Medical Oncology Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Radiation Oncology Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Projects 2019 2020

Research Output 2013 2019

Initial treatment and survival in a national unselected Danish cohort of 4163 patients with pancreatic cancer

Rasmussen, L. S., Vittrup, B., Ladekarl, M., Pfeiffer, P., Yilmaz, M. K., Poulsen, L. Ø., Østerlind, K., Skuladottir, H., Hansen, C. P., Mortensen, M. B., Mortensen, F. V., Sall, M., Falkmer, U. G. I. & Fristrup, C., 2019.

Research output: Contribution to conference without publisher/journalPosterCommunication

Open Access
File

Initial treatment and survival in a national unselected Danish cohort of 4163 patients with pancreatic cancer

Rasmussen, L. S., Vittrup, B., Ladekarl, M., Pfeiffer, P., Yilmaz, M. K., Poulsen, L. Ø., Østerlind, K., Skuladottir, H., Hansen, C. P., Mortensen, M. B., Mortensen, F. V., Sall, M., Falkmer, U. G. I. & Fristrup, C., 2019.

Research output: Contribution to conference without publisher/journalPosterCommunication

Open Access
File

Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer

Rasmussen, L. S., Yilmaz, M., Falkmer, U. G., Poulsen, L. O., Bojesen, S. E., Jensen, B. V., Johansen, A. Z., Chen, I. M., Hansen, C. P., Hasselby, J. P., Pfeiffer, P., Bjerregaard, J. K., Nielsen, S. E., Andersen, F. Z., Hollander, N. H., Bogsted, M. & Johansen, J. S., 1 Oct 2019, In : Annals of Oncology. 30, Suppl. 5, 699P.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Randomized study evaluating trifluridine/tipiracil (TAS-102) versus + trifluridine/tipiracil + bevacizumab as last-line therapy in patients with chemorefractory unresectable metastatic colorectal cancer (mCRC).

Pfeiffer, P., Yilmaz, M., Möller, S., Maltha, L., Krogh, M., Zitnjak, D., Szameitat, C. L., Poulsen, L. Ø., Thomsen, K. G. & Qvortrup, C., 2019, In : Journal of Clinical Oncology. 37, Suppl. 4, 637.

Research output: Contribution to journalJournal articleResearchpeer-review

2 Citations (Scopus)

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Winther, S. B., Liposits, G., Skuladottir, H., Hofsli, E., Shah, C-H., Poulsen, L. Ø., Ryg, J., Osterlund, P., Berglund, Å., Qvortrup, C., Glimelius, B., Sorbye, H. & Pfeiffer, P., May 2019, In : The Lancet Gastroenterology & Hepatology. 4, 5, p. 376-388 13 p.

Research output: Contribution to journalJournal articleResearchpeer-review

oxaliplatin
Combination Drug Therapy
Colorectal Neoplasms
irinotecan
Therapeutics